Zejula savings card: as little as $0 a fill with commercial insurance

How to pay the least

Ask for the cash price

Zejula

We didn’t find one.

Ask your pharmacy for Zejula’s cash price, and one or two other pharmacies too.
Zejula’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify GSK Patient Assistance Program (prescription medicines). Or call 1-866-728-4368.

See if you qualify

Compare every option

Brand nameZejula

Authorized genericniraparib

Regular genericniraparib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Zejula?

The original

–

Brand nameThe maker’s card

ZEJULA Copay Program

Savings card from GSK

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a fill

Or call 1-844-447-5662.

In the maker’s words

“Eligible, commercially insured patients may pay as little as $0 for ZEJULA…”

From the maker’s offer on zejulaco-pay.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Zejula itself, from the same company, sold without the brand name, and usually for less. For now Zejula is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Ovarian, fallopian tube or peritoneal cancer

What the FDA label says

ZEJULA is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated:

for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD)-positive status defined by either:
- oa deleterious or suspected deleterious BRCA mutation, and/or
- ogenomic instability.
- Select patients for therapy based on an FDA‑authorized companion diagnostic for ZEJULA.
for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. Select patients for therapy based on an FDA‑authorized companion diagnostic for ZEJULA.

Source: the FDA label for Zejula (GlaxoSmithKline LLC), July 28, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/zejula/